Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S0140-6736(21)00712-1 http://scihub22266oqcxt.onion/10.1016/S0140-6736(21)00712-1 33933194!8084409!33933194     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet 2021 ; 397 (10285): 1599-1601 Nephropedia Template TP {{tp|p=33933194|t=2021. Tocilizumab in COVID-19: some clarity amid controversy |pdf=|usr=}}{{33933194}} gab.com Text Tocilizumab in COVID-19: some clarity amid controversy JO: Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33933194 #FOAvip ä Twit Text FOAVip Tocilizumab in COVID-19: some clarity amid controversy ????Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33933194 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33933194 #FOAvip English Wikipedia <ref>{{Cite pmid|33933194}}</ref> Tocilizumab in COVID-19: some clarity amid controversy #MMPMID33933194 Gupta S; Leaf DE Lancet 2021[May]; 397 (10285): 1599-1601 PMID33933194show ga ä |*COVID-19 Drug Treatment[MESH] |Antibodies, Monoclonal, Humanized[MESH] |Hospitals[MESH] |Humans[MESH]Tocilizumab in COVID-19: some clarity amid controversy (epmc).pdf DeepDyve Pubget Overpricing